# Assessing Tissue Remodeling in the Skin Using SFI (Skin Fluorescence Imaging)

> **NCT03535077** · — · COMPLETED · sponsor: **Orlucent, Inc** · enrollment: 186 (actual)

## Conditions studied

- Skin Lesion
- Melanoma (Skin)
- Mole

## Interventions

- **OTHER:** Diagnostic Test

## Key facts

- **NCT ID:** NCT03535077
- **Lead sponsor:** Orlucent, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-24
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 186 (ACTUAL)
- **Last updated:** 2024-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03535077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03535077, "Assessing Tissue Remodeling in the Skin Using SFI (Skin Fluorescence Imaging)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03535077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*